Clinical features and 123I-FP-CIT SPECT imaging in vascular parkinsonism and Parkinson's disease

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 84, Issue 2, 2013, Pages 122-129

  Benítez Rivero, Sonia ^a   Marín Oyaga, Víctor A ^a   García Solís, David ^a,b   Huertas Fernández, Ismael ^a   García Gomez, Francisco J ^a   Jesus, Silvia ^a   Caceres, María Teresa ^a   Carrillo, Fatima ^a   Ortiz, Ana M ^a   Carballo, Manuel ^a   Mir, Pablo ^a,b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED SOBRE ENFERMEDADES NEURODEGENERATIVAS CIBERNED   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE RECEPTOR STIMULATING AGENT; DOPAMINE TRANSPORTER; IOFLUPANE I 123; LEVODOPA; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; RADIOACTIVE IODINE; TROPANE DERIVATIVE;

AGE; AGED; ARTICLE; BALANCE DISORDER; CASE CONTROL STUDY; CAUDATE NUCLEUS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORPUS STRIATUM; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DISEASE DURATION; DRUG RESPONSE; FALLING; FEMALE; GAIT DISORDER; HOEHN AND YAHR SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PARKINSONISM; PREDICTIVE VALUE; PRIORITY JOURNAL; PUTAMEN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREMOR; VASCULAR PARKINSONISM; BRAIN; CEREBROVASCULAR DISEASE; FUNCTIONAL NEUROIMAGING; METABOLISM; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; STATISTICS;

AGED; BRAIN; CASE-CONTROL STUDIES; CEREBROVASCULAR DISORDERS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; FUNCTIONAL NEUROIMAGING; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSON DISEASE, SECONDARY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

MLCS; MLOWN;

EID: 84872677723     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp-2012-302618     Document Type: Article

References (35)

1. Critchley M. Arteriosclerotic parkinsonism. Brain 1929;52:23e83.
2. Thanvi B, Lo N, Robinson T. Vascular parkinsonismdan important cause of parkinsonism in older people. Age Ageing 2005;34:114e19.
3. Tolosa ES, Santamaría J. Parkinsonism and basal ganglia infarcts. Neurology 1984;34:1516e18.
4. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur Neurol 1989;29:164e8.
5. Yamanouchi H, Nagura H. Cerebrovascular parkinsonism-clinicopathologic study. Rinsho Shinkeigaku 1995;35:1457e8.
6. Rampello L, Alvano A, Battaglia G, et al. Different clinical and evolutional patterns in late idiopathic and vascular parkinsonism. J Neurol 2005;252:1045e9.
7. Hughes AJ, Daniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psych 1992;55:181e4.
8. 123I]b-CIT striatal uptake correlates with symptom severity in idiopathic Parkinson's disease. Ann Neurol 1995;38:589e98.
9. 123I] b-CIT SPECT distinguishes vascular parkinsonism from Parkinson's disease. Mov Disord 2002;17:518e23.
10. Sibon I, Fenelon G, Quinn NP, et al. Vascular parkinsonism. J Neurol 2004;251:513e24.
11. Kalra S, Grosset DG, Benamer HT. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review. Mov Disord 2010;25:149e56.
12. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand 2001;104:63e7.
13. 123I-FP-CIT SPECT imaging of dopamine transporters in patients with cerebrovascular disease and clinical diagnosis of vascular parkinsonism. J Nucl Med 2004;45:1688e93.
14. 123I] FP-CIT SPECT study in vascular parkinsonism and Parkinson's disease. Mov Disord 2007;22:1278e85.
15. Zijlmans J, Daniel S, Hughes A, et al. Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 2004;19:630e40.
16. Benamer TS, Patterson J, Grosset DG, et al. Accurate differentiation of parkinsonism and essential tremor using visual assessment of [123I]-FP-CIT SPECT imaging: the [123I]-FP-CIT study group. Mov Disord 2000;15:503e10.
17. Winikates J, Jankovic J. Clinical correlates of vascular parkinsonism. Arch Neurol 1999;56:98e102.
18. Chang CM, Yu YL, Ng HK, et al. Vascular pseudoparkinsonism. Acta Neurol Scand 1992;86:588e92.
19. Fitzgerald P, Jankovic J. Lower body parkinsonism: evidence of vascular etiology. Mov Disord 1989;4:249e60.
20. Jellinger KA. Vascular parkinsonism-neuropathological findings. Acta Neurol Scand 2002;105:414e15.
21. Sibon I, Tison F. Vascular parkinsonism. Curr Opin Neurol 2004;17:49e54.
22. Inzelberg R, Bornstein NM, Reider I, et al. Basal ganglia lacunes and parkinsonism. Neuroepidemiology 1994;13:108e12.
23. Yamanouchi H, Nagura H. Neurological signs and frontal white matter lesions in vascular parkinsonism: a clinicopathologic study. Stroke 1997;28:965e9.
24. Fenelon G, Houeto JL. Vascular Parkinson syndromes: a controversial concept. Rev Neurol 1998;154:291e302.
25. Peters S, Eising EG, Przuntek H, et al. Vascular parkinsonism: a case report and review of the literature. J Clin Neurosci 2001;8:268e71.
26. van Zagen M, Lodder J, Kessels F. Gait disorder and parkinsonian signs in patients with stroke related to small deep infarcts and white matter lesions. Mov Disord 1998;13:89e95.
27. Benamer HT, Grosset DG. Vascular parkinsonism: a clinical review. Eur Neurol 2009;61:11e15.
28. Gomes da Silva E, Viana MA, Quagliato EM. Vascular parkinsonism: analysis of seven cases. Arq Neuropsiquiatr 2006;64:568e71.
29. Gupta D, Kuruvilla A. Vascular parkinsonism: what makes it different? Postgrad Med J 2011;87:829e36.
30. Constantinescu R, Richard I, Kurlan R. Levodopa responsiveness in disorders with parkinsonism: a review of the literature. Mov Disord 2007;22:2141e8.
31. Zijlmans JC, Katzenschlager R, Daniel SE, et al. The L-dopa response in vascular parkinsonism. J Neurol Neurosurg Psychiatry 2004;75:545e7.
32. Zijlmans J, Jan CM. The role of imaging in the diagnosis of vascular parkinsonism. Neuroimag Clin N Am 2010;20:69e76.
33. 123I]FP-CIT- SPECT asymmetry index to differentiate Parkinson's disease from vascular parkinsonism. Acta Neurol Scand 2012;126:12e16.
34. 123I-FP-CIT SPECT images in the diagnosis of Parkinsonian syndrome. Rev Esp Med Nucl 2011;30:229e35.
35. Scherfler C, Nocker M. Dopamine transporter SPECT: how to remove subjectivity? Mov Disord 2009;24:721e4.